SML2392

DREADD Agonist 21 dihydrochloride

≥98% (HPLC), powder, DREADD agonist

• 동의어(들): 11-(1-piperazinyl)-5H-Dibenzo[b,e][1,4]diazepine dihydrochloride, 11-(Piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine; 11-Piperazinyldibenzo[b,e][1,4]diazepine dihydrochloride, Compound 21 dihydrochloride
• 실험식(Hill 표기법): C₁₇H₁₈N₄ · 2HCl
• CAS Number: 56296-18-5
• Molecular Weight: 351.27
• MDL number: MFCD25121806
• UNSPSC 코드: 12352200
• NACRES: NA.77

속성

• 제품명: DREADD Agonist 21 dihydrochloride, ≥98% (HPLC)
• 분석: ≥98% (HPLC)
• 양식: powder
• 저장 조건: desiccated
• 색상: yellow to brown
• solubility: H₂O: 2 mg/mL, clear
• 저장 온도: −20°C
• SMILES string: C1(C=CC=C2)=C2C(N3CCNCC3)=NC(C=CC=C4)=C4N1
• InChI: 1S/C17H18N4/c1-2-6-14-13(5-1)17(21-11-9-18-10-12-21)20-16-8-4-3-7-15(16)19-14/h1-8,18-19H,9-12H2
• InChI key: JCBYXNSOLUVGTF-UHFFFAOYSA-N

설명

생화학적/생리학적 작용

Compound 21 is a potent designer drug with full agonist activity toward human hM3Dq (EC50 = 1.7 nM by cell-based Ca2+ mobilization assay), a human M3 muscarinic receptor (M3R)-based Gq (M3Dq) DREADD (Designer Receptors Exclusively Activated by Designer Drugs), displaying little activity toward muscarinic acetylcholine receptor M3 (30% M3 activation at 10 μM) and reduced affinity toward H1, 5HT2A, 5HT2C, α1A receptor (fold selectivity = 3.5, 40, 100, 165, respectively). Note: the DREADD hM3Dq exhibits M3 biological activity, but is insensitive to the endogenous ligand acetylcholine (ACh).

Potent designer drug with selective agonist activity for human M3Dq (hM3Dq) DREADD (Designer Receptors Exclusively Activated by Designer Drugs).

안전성 정보

• 픽토그램: GHS07
• 신호어: Warning
• 유해 및 위험 성명서: H302
• 예방조치 성명서: P264 - P270 - P301 + P312 - P501
• Hazard Classifications: Acute Tox. 4 Oral
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3
• Flash Point (°F): Not applicable
• Flash Point (°C): Not applicable